Basic fibroblast growth factor modifies the hypoxic response of human bone marrow stromal cells by ERK-mediated enhancement of HIF-1α activity

Stem Cell Research

Volumn 12, Issue 3, 2014, Pages 646-658

  Fábián, Zsolt ^a   Ramadurai, Sivaramakrishnan ^a   Shaw, Georgina ^a   Nasheuer, Heinz Peter ^a   Kolch, Walter ^b   Taylor, Cormac ^b   Barry, Frank ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; FIBROBLAST GROWTH FACTOR 2; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LAMIN B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NUCLEOLIN; PHOSPHOGLYCERATE KINASE; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE B; TRIOSEPHOSPHATE ISOMERASE; VASCULOTROPIN; OXYGEN; PROTEIN BINDING;

ARTICLE; BONE MARROW CELL; BONE MARROW STROMAL CELL; CELL HYPOXIA; CELL POPULATION; CELL STRUCTURE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE CORRELATION SPECTROSCOPY; GENE EXPRESSION; HUMAN; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION; CELL PROLIFERATION; CYTOLOGY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PROMOTER REGION;

CELL HYPOXIA; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; OXYGEN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; UP-REGULATION;

EID: 84897852338     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.02.007     Document Type: Article

References (59)

1. Bancaud A., Huet S., Daigle N., Mozziconacci J., Beaudouin J., Ellenberg J. Molecular crowding affects diffusion and binding of nuclear proteins in heterochromatin and reveals the fractal organization of chromatin. Embo J. 2009, 28:3785-3798.
2. Bardos J.I., Chau N.M., Ashcroft M. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression. Mol. Cell. Biol. 2004, 24:2905-2914.
3. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
4. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
5. Bilton R.L., Booker G.W. The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur. J. Biochem. 2003, 270:791-798.
6. Brazda P., Szekeres T., Bravics B., Toth K., Vamosi G., Nagy L. Live-cell fluorescence correlation spectroscopy dissects the role of coregulator exchange and chromatin binding in retinoic acid receptor mobility. J. Cell Sci. 2011, 124:3631-3642.
7. Broderick R., Ramadurai S., Toth K., Togashi D.M., Ryder A.G., Langowski J., Nasheuer H.P. Cell cycle-dependent mobility of Cdc45 determined in vivo by fluorescence correlation spectroscopy. PLoS One 2012, 7:e35537.
8. Bruning U., Cerone L., Neufeld Z., Fitzpatrick S.F., Cheong A., Scholz C.C., Simpson D.A., Leonard M.O., Tambuwala M.M., Cummins E.P., et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 2011, 31:4087-4096.
9. Carbonaro M., Escuin D., O'Brate A., Thadani-Mulero M., Giannakakou P. Microtubules regulate hypoxia-inducible factor-1alpha protein trafficking and activity: implications for taxane therapy. J. Biol. Chem. 2012, 287:11859-11869.
10. Chan D.A., Sutphin P.D., Denko N.C., Giaccia A.J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 2002, 277:40112-40117.
11. Chen Y., Li X., Eswarakumar V.P., Seger R., Lonai P. Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation. Oncogene 2000, 19:3750-3756.
12. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., Zhang J.J., Chunhua R.Z., Liao L.M., Lin S., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 2004, 94:92-95.
13. Chikazu D., Hakeda Y., Ogata N., Nemoto K., Itabashi A., Takato T., Kumegawa M., Nakamura K., Kawaguchi H. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J. Biol. Chem. 2000, 275:31444-31450.
14. Chow D.C., Wenning L.A., Miller W.M., Papoutsakis E.T. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. Biophys. J. 2001, 81:675-684.
15. Cuevas P., Carceller F., Ortega S., Zazo M., Nieto I., Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 1991, 254:1208-1210.
16. Dertinger T., Pacheco V., von der Hocht I., Hartmann R., Gregor I., Enderlein J. Two-focus fluorescence correlation spectroscopy: a new tool for accurate and absolute diffusion measurements. Chemphyschem: Eur. J. Chem. Phys. Phys. Chem. 2007, 8:433-443.
17. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
18. Dos Santos F., Andrade P.Z., Boura J.S., Abecasis M.M., da Silva C.L., Cabral J.M. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J. Cell. Physiol. 2010, 223:27-35.
19. Eisemann A., Ahn J.A., Graziani G., Tronick S.R., Ron D. Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 1991, 6:1195-1202.
20. Enobakhare B.O., Bader D.L., Lee D.A. Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue. Anal. Biochem. 1996, 243:189-191.
21. Fabian Z., O'Brien P., Pajecka K., Fearnhead H.O. TPCK-induced apoptosis and labelling of the largest subunit of RNA polymerase II in Jurkat cells. Apoptosis 2009, 14:1154-1164.
22. Fitzpatrick S.F., Tambuwala M.M., Bruning U., Schaible B., Scholz C.C., Byrne A., O'Connor A., Gallagher W.M., Lenihan C.R., Garvey J.F., et al. An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. J. Immunol. 2011, 186:1091-1096.
23. Fritsch C.C., Langowski J. Chromosome dynamics, molecular crowding, and diffusion in the interphase cell nucleus: a Monte Carlo lattice simulation study. Chromosom. Res.: Int. J. Mol., Supramol. Evol. Asp. Chromosom. Biol. 2011, 19:63-81.
24. Fulgham D.L., Widhalm S.R., Martin S., Coffin J.D. FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium 1999, 6:185-195.
25. Grayson W.L., Zhao F., Bunnell B., Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2007, 358:948-953.
26. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., Yang H., Sorokina I., Conaway R.C., Conaway J.W., et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13459-13464.
27. Jeyasekharan A.D., Ayoub N., Mahen R., Ries J., Esposito A., Rajendra E., Hattori H., Kulkarni R.P., Venkitaraman A.R. DNA damage regulates the mobility of Brca2 within the nucleoplasm of living cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21937-21942.
28. Jin Y., Kato T., Furu M., Nasu A., Kajita Y., Mitsui H., Ueda M., Aoyama T., Nakayama T., Nakamura T., et al. Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase. Biochem. Biophys. Res. Commun. 2010, 391:1471-1476.
29. Johnson D.E., Lu J., Chen H., Werner S., Williams L.T. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 1991, 11:4627-4634.
30. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 1998, 238:265-272.
31. Kanichai M., Ferguson D., Prendergast P.J., Campbell V.A. Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha. J. Cell. Physiol. 2008, 216:708-715.
32. Macmillan M.L., Blazar B.R., DeFor T.E., Wagner J.E. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant. 2009, 43:447-454.
33. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
34. Martin I., Muraglia A., Campanile G., Cancedda R., Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997, 138:4456-4462.
35. Masson N., Willam C., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. Embo J. 2001, 20:5197-5206.
36. Mazzini L., Ferrero I., Luparello V., Rustichelli D., Gunetti M., Mareschi K., Testa L., Stecco A., Tarletti R., Miglioretti M., et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp. Neurol. 2010, 223:229-237.
37. Miller D.L., Ortega S., Bashayan O., Basch R., Basilico C. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol. Cell. Biol. 2000, 20:2260-2268.
38. Minet E., Arnould T., Michel G., Roland I., Mottet D., Raes M., Remacle J., Michiels C. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 2000, 468:53-58.
39. Mohammadi M., Olsen S.K., Ibrahimi O.A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 2005, 16:107-137.
40. Mylonis I., Chachami G., Paraskeva E., Simos G. Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1alpha by MAPK. J. Biol. Chem. 2008, 283:27620-27627.
41. Park S.Y., Barron E., Suh P.G., Ryu S.H., Kay E.P. FGF-2 facilitates binding of SH3 domain of PLC-gamma1 to vinculin and SH2 domains to FGF receptor in corneal endothelial cells. Mol. Vis. 1999, 5:18.
42. Perez-Simon J.A., Lopez-Villar O., Andreu E.J., Rifon J., Muntion S., Campelo M.D., Sanchez-Guijo F.M., Martinez C., Valcarcel D., Canizo C.D. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica 2011, 96:1072-1076.
43. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
44. Richard D.E., Berra E., Gothie E., Roux D., Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 1999, 274:32631-32637.
45. Robey P.G., Bianco P. The use of adult stem cells in rebuilding the human face. J. Am. Dent. Assoc. 2006, 137:961-972.
46. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., Tagliafico E., Ferrari S., Robey P.G., Riminucci M., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
47. Sang N., Stiehl D.P., Bohensky J., Leshchinsky I., Srinivas V., Caro J. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J. Biol. Chem. 2003, 278:14013-14019.
48. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007, (2007, cm8).
49. Sleeman M., Fraser J., McDonald M., Yuan S., White D., Grandison P., Kumble K., Watson J.D., Murison J.G. Identification of a new fibroblast growth factor receptor, FGFR5. Gene 2001, 271:171-182.
50. Tondevold E., Eriksen J., Jansen E. Observations on long bone medullary pressures in relation to arterial PO2, PCO2 and pH in the anaesthetized dog. Acta Orthop. Scand. 1979, 50:645-651.
51. Tsai C.C., Chen Y.J., Yew T.L., Chen L.L., Wang J.Y., Chiu C.H., Hung S.C. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood 2011, 117:459-469.
52. Volkmer E., Kallukalam B.C., Maertz J., Otto S., Drosse I., Polzer H., Bocker W., Stengele M., Docheva D., Mutschler W., et al. Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue Eng. Part A 2010, 16:153-164.
53. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 1995, 270:1230-1237.
54. 2 tension. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:5510-5514.
55. Willam C., Nicholls L.G., Ratcliffe P.J., Pugh C.W., Maxwell P.H. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha. Adv. Enzym. Regul. 2004, 44:75-92.
56. Wotzlaw C., Otto T., Berchner-Pfannschmidt U., Metzen E., Acker H., Fandrey J. Optical analysis of the HIF-1 complex in living cells by FRET and FRAP. FASEB J. 2007, 21:700-707.
57. Yoon J., Deisboeck T.S. Investigating differential dynamics of the MAPK signaling cascade using a multi-parametric global sensitivity analysis. PLoS One 2009, 4:e4560.
58. Yu P.J., Ferrari G., Galloway A.C., Mignatti P., Pintucci G. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J. Cell. Biochem. 2007, 100:1100-1108.
59. Zhou M., Sutliff R.L., Paul R.J., Lorenz J.N., Hoying J.B., Haudenschild C.C., Yin M., Coffin J.D., Kong L., Kranias E.G., et al. Fibroblast growth factor 2 control of vascular tone. Nat. Med. 1998, 4:201-207.